Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease

Clinical trial NCT04311567 · TERMINATED

Trial details

NCT number: NCT04311567
Sponsor: Vastra Gotaland Region
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis Interstitial Lung Disease Due to Systemic Disease (Disorder)RA ILD

Start date: 2020-11-07
Primary completion: 2023-11-30
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.